Abstract
In castor oil challenged rats, low doses of loperamide inhibit diarrhea and normalize intestinal propulsion. Unlike other opioids, loperamide is devoid of central opiate-like effects, including blockade of intestinal propulsion, up to the highest subtoxic oral dose. Nevertheless, the antidiarrheal action of loperamide can be considered to be μ-opiate receptor mediated, only a fewin vitro effects at rather high concentrations being not naloxone-reversible. There is little evidence that interactions with intestinal opiate receptors directly change epithelial cell function. When secretory stimuli increase mucosal tension, however, loperamide may reverse the elevated hydrostatic tissue pressure that opposes normal absorption. This antisecretory effect at the mucosal level is accompanied by motor effects when loperamide reaches the myenteric μ-opiate receptors. At therapeutic doses for the treatment of acute diarrhea, it is likely that the mucosal effect prevails.
Similar content being viewed by others
References
Niemegeers CJE, Colpaert FC, Awouters FHL: Pharmacology and antidiarrheal effect of loperamide. Drug Dev Res 1:1–20, 1981
Niemegeers CJE, Lenaerts FM, Janssen PAJ: Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1:In vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine. Arzneim-Forsch (Drug Res) 24:1633–1636, 1974
Karim SMM, Adaikan PG: The effect of loperamide on prostaglandin induced diarrhoea in rat and man. Prostaglandins 13:321–331, 1977
Shee CD, Pounder RE: Loperamide, diphenoxylate, and codeine phosphate in chronic diarrhoea. Br Med J 1:524, 1980
Kromer W: Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion. Pharmacol Rev 40:121–162, 1988
Wüster M, Herz A: Opiate agonist action of antidiarrheal agentsin vitro andin vivo—findings in support for selective action. Naunyn-Schmiedeberg's Arch Pharmacol 301:187–194, 1978
Mackerer CR, Clay GA, East PF: Review of the involvement of opiate receptors in producing the central and peripheral effects caused by two new antidiarrheal drugs, loperamide and SC-27166. J Am Coll Toxicol 3:81–91, 1984
Leysen J, Laduron P: Aspecific binding, an important factor in drug action? J Pharmacol (Paris) 8:565–566, 1977
Niemegeers CJE, McGuire JL, Heykants JJP, Janssen PAJ: Dissociation between opiate-like and antidiarrheal activities of antidiarrheal drugs. J Pharmacol Exp Ther 210:327–333, 1979
Heykants J, Michiels M, Knaeps A, Brugmans J: Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: The pharmacokinetics of loperamide in rats and man. Arzneim-Forsch (Drug Res) 24:1649–1653, 1974
Van Nueten JM, Helsen L, Michiels M, Heykants JJP: Distribution of loperamide in the intestinal wall. Biochem Pharmacol 28:1433–1434, 1979
Dashwood MR, Sykes RM, Thomson CS: Autoradiographic demonstration of [3H]loperamide binding to opioid receptors in rat and human small intestine. International Narcotics Research Conference (INRC) 89:165–169, 1990
Van Nueten JM, Fontaine J:In vitro pharmacology: Study of the peristaltic reflex and other experiments on isolated tissues.In Synthetic Antidiarrheal Drugs. W Van Bever and H Lal (eds). Marcel Dekker, New York, 1976, pp 114–132
Hubel KA: Intestinal nerves and ion transport: stimuli, reflexes, and responses. Am J Physiol 248:G261-G271, 1985
Caren JF, Meyer JH, Grossman MI: Canine intestinal secretion during and after rapid distention of the small bowel. Am J Physiol 227:183–188, 1974
Cooke HJ, Shonnard K, Wood JD: Effects of neuronal stimulation on mucosal transport in guinea pig ileum. Am J Physiol 245:G290-G296, 1983
See NA, Greenwood B, Bass P: Submucosal plexus alone integrates motor activity and epithelial transport in rat jejunum. Am J Physiol 259:G593-G598, 1990
Megens AAHP, Canters LLJ, Awouters FHL, Niemegeers CJE: Normalization of small intestinal propulsion with loperamide-like antidiarrheals in rats. Eur J Pharmacol 17:357–364, 1990
Megens AAHP, Canters LLJ, Awouters FHL, Niemegeers CJE: Isin vivo dissociation between the antipropulsive and antidiarrheal properties of opioids in rats related to gut selectivity? Arch Int Pharmacodyn Ther 298:220–229, 1989
Théodorou V, Fioramonti J, Hachet T, Buéno L: Absorptive and motor components of the antidiarrheal action of loperamide: Anin vivo study in pigs. Gut 32:1355–1359, 1991
Van Wyk M, Sommers DK, Steyn AGW: Evaluation of gastrointestinal motility using the hydrogen breath test. Br J Clin Pharmacol 20:479–481, 1985
Corbett CL, Thomas S, Read NW, Hobson N, Bergman I, Holdsworth CD: Electrochemical detector for breath hydrogen determination: measurement of small bowel transit time in normal subjects and patients with the irritable bowel syndrome. Gut 22:836–840, 1981
O'Brien JD, Thompson DG, McIntyre A, Burnham WR, Walker E: Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea. Gut 29:312–318, 1988
Basilisco G, Bozzani A, Camboni G, Recchia M, Quatrini M, Conte D, Penagini R, Bianchi PA: Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test. Gut 26:700–703, 1985
Basilisco G, Camboni G, Bozzani A, Bianchi PA: Loperamide and oro-caecal transit delay. Br J Clin Pharmacol 22:371–372, 1986
Basilisco G, Camboni G, Bozzani A, Paravicini M, Bianchi PA: Oral naloxone antagonizes loperamide-induced delay of orocecal transit. Dig Dis Sci 32:829–832, 1987
Sninsky CA, Davis RH, Clench MH, Thomas KD, Mathias JR: Effect of lidamidine hydrochloride and loperamide on gastric emptying and transit of the small intestine. Gastroenterology 90:68–73, 1986
Kirby MG, Dukes GE, Heizer WD, Bryson JC, Powell JR: Effect of metoclopramide, bethanechol, and loperamide on gastric residence time, gastric emptying, and mouth-tocecum transit time. Pharmacotherapy 9:226–231, 1989
Bryson JC, Dukes GE, Kirby MG, Heizer WD, Powell JR: Effect of altering small bowel transit time on sustained release theophylline absorption. J Clin Pharmacol 29:733–738, 1989
Hughes S, Higgs NB, Turnberg LA: Loperamide has antisecretory activity in the human jejunumin vivo. Gut 25:931–935, 1984
Kachel G, Ruppin H, Hagel J, Barina W, Meinhardt M, Domschke W: Human intestinal motor activity and transport: Effects of a synthetic opiate. Gastroenterology 90:85–93, 1986
Press AG, Ewe K, Schmidt J, Junge H: Effect of loperamide on jejunal electrolyte and water transport, prostaglandin E2-induced secretion and intestinal transit time in man. Eur J Clin Pharmacol 41:239–243, 1991
Holgate AM, Read NW: Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose. Dig Dis Sci 28:812–819, 1983
Bond JH, Levitt MD: Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med 85:546–555, 1975
Di Lorenzo C, Dooley CP, Valenzuela JE: Role of fasting gastrointestinal motility in the variability of gastrointestinal transit time assessed by hydrogen breath test. Gut 32:1127–1130, 1991
Friedman G, Korsten M: Small bowel motility patterns in humans following orally administered anti-diarrheal drugs. Gastroenterology 72:A36, 1059, 1977
Krüger H: The action of morphine on the digestive tract. Physiol Rev 17:618–645, 1937
Farack UM, Loeschke K: Inhibition of loperamide by deoxycholic acid induced intestinal secretion. Naunyn-Schmiedeberg's Arch Pharmacol 325:286–289, 1984
Ahsan MA, Ilundain A, Naftalin RJ, Sandhu BK, Smith PM: Effects of theophylline, choleragen and loperamide on rabbit ileal fluid and electrolyte transportin vitro. Br J Pharmacol 92:743–754, 1987
Coupar IM: Minireview. Opioid action on the intestine: the importance of the intestinal mucosa. Life Sci 41:917–925, 1987
Greenwood B, Davison SJ: The relationship between gastrointestinal motility and secretion. Am J Physiol 252:G1-G7, 1987
Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS: Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 86:1475–1480, 1984
Rolston DDK, Zinzuvadia SN, Mathan VI: Evaluation of the efficacy of oral rehydration solutions using human whole gut perfusion. Gut 31:1115–1119, 1990
Niemegeers CJE, Awouters F, Lenaerts FM, Artois KSK, Vermeire J: Antidiarrheal specificity and safety of theN-oxide of loperamide (R 58 425) in rats. Drug Div Res 8:279–286, 1986
Stewart CP, Turnberg LA: A microelectrode study of responses to secretagogues by epithelial cells on villus and crypt of rat small intestine. Am J Physiol 257:G334-G343, 1989
Sjöqvist A, Beeuwkes R: Villus and crypt electrolyte and fluid transport during intestinal secretion. Acta Physiol Scand 139:203–210, 1990
Sundqvist T, Magnusson K-E: Modelling of intestinal permeability in man to polyethyleneglycols (PEG 400 and PEG 1000). Acta Physiol Scand 125:289–296, 1986
Ewe K, Wanitschke R, Staritz M: Intestinal permeability studies in humans.In Pharmacology of Intestinal Permeation. Handbook of Experimental Pharmacology, 70/II TZ Csaky (ed). Springer-Verlag, Berlin, 1984, pp 535–571
Davis GR, Santa Ana CA, Morawski SG, Fordtran JS: Permeability characteristics of human jejunum, ileum, proximal colon and distal colon: Results of potential difference measurements and unidirectional fluxes. Gastroenterology 83:844–850, 1982
Granger DN: Intestinal microcirculation and transmucosal fluid transport. Am J Physiol 240:G343-G349, 1981
Winne D: The influence of blood flow and water net flux on the absorption of tritiated water from the jejunum of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 272:417–436, 1972
Winne D: Role of blood flow in intestinal permeation.In Pharmacology of Intestinal Permeation. Handbook of Experimental Pharmacology, 70/II, TZ Csaky (ed). Springer-Verlag, Berlin, 1984, pp 301–347
Joyce NC, Haire MF, Palade GE: Morphologic and biochemical evidence for a contractile cell network within the rat intestinal mucosa. Gastroenterology 92:68–81, 1987
Keast JR: Mucosal innervation and control of water and ion transport in the intestine. Rev Physiol Biochem Pharmacol 109:1–59, 1987
Bridges RJ, Rummel W: Mechanistic basis of alterations in mucosal water and electrolyte transport. Clin Gastroenterol 15:491–506, 1986
Cooke HJ: Influence of enteric cholinergic neurons on mucosal transport in guinea pig ileum. Am J Physiol 246:G263-G267, 1984
Isaacs PET, Corbett CL, Riley AK, Hawker PC, Turnberg LA:In vitro behavior of human intestinal mucosa. The influence of acetylcholine on ion transport. J Clin Invest 58:535–542, 1976
Bornstein J, Furness J: Correlated electrophysiological and histochemical studies of submucous neurons and their contribution to understanding enteric neural circuits. J Auton Nerv Syst 25:1–13, 1988
Sjöqvist A, Beeuwkes R: Antisecretory effect of splanchnic nerve stimulation on choleratoxin-induced secretion in the cat, an effect mediated at the crypts. Acta Physiol Scand 142:359–365, 1991
Lundgren O, Svanvik J, Jivegård L: Enteric nervous system. I. Physiology and pathophysiology of the intestinal tract. Dig Dis Sci 34:264–283, 1989
Sjöqvist A: Interaction between antisecretory opioid and sympathetic mechanisms in the rat small intestine. Acta Physiol Scand 142:127–132, 1991
Read NW: Diarrhée motrice. Clin Gastroenterol 15:657–686, 1986
Swabb EA, Hynes RA, Marnane WG, McNeil JS, Decker RA, Tai Y-H, Donowitz M: Intestinal filtration secretion due to increased intraluminal pressure in rabbits. Am J Physiol 242:G65-G75, 1982a
Swabb EA, Hynes RA, Donowitz M: Elevated intraluminal pressure alters rabbit small intestinal transportin vivo. Am J Physiol 242:G58-G64, 1982
Yablonski ME, Lifson N: Mechanism of production of small intestinal secretion by elevated venous pressure. J Clin Invest 57:904–915, 1976
Lee JS: Contraction of villi and fluid transport in dog jejunal mucosain vitro. Am J Physiol 221:488–495, 1971
Lee JS: Relationship between intestinal motility, tone, water absorption and lymph flow in the rat. J Physiol 345:489–499, 1983
Berschneider HM, Martens H, Powell DW: Effect of BW 942C, an enkephalinlike pentapeptide, on sodium and chloride transport in the rabbit ileum. Gastroenterology 94:127–136, 1988
Mailman D: Effects of morphine on canine intestinal absorption and blood flow. Br J Pharmacol 68:617–624, 1980
Mailman D: Morphine-neural interactions on canine intestinal absorption and blood flow. Br J Pharmacol 81:263–270, 1984
Bianchi C, Goi A: On the antidiarrhoeal and analgesic properties of diphenoxylate, difenoxine and loperamide in mice and rats. Arzneim-Forsch (Drug Res) 27(I):1040–1043, 1977
Dajani EZ, Bianchi RG, East PF, Bloss JL, Adelstein GW, Yen CH: The pharmacology of SC-27166: A novel antidiarrheal agent. J Pharmacol Exp Ther 203:512–526, 1977
Fioramonti J, Buéno L: Effects of loperamide hydrochloride on experimental diarrhea and gastrointestinal myoelectrical activity in calves. Am J Vet Res 48:415–419, 1987
Mir GN, Alioto RL, Sperow JW, Eash JR, Krebs JB, Yelnosky J:In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Arzneim-Forsch (Drug Res) 28:1448–1454, 1978
Sohji Y, Kawashima K, Nakamura H, Shimizu M: Pharmacological studies of loperamide, an antidiarrheal agent. Part 1. Effects on diarrhea induced by castor oil and prostaglandin E1. Folia Pharm Jpn 74:145–154, 1978
Clay GA, Mackerer CR, Lin TK: Interaction of loperamide with [3H]naloxone binding sites in guinea pig brain and myenteric plexus. Mol Pharmacol 13:533–540, 1977
Mackerer CR, Clay GA, Dajani EZ: Loperamide binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther 199:131–140, 1976
Mackerer CR, Brougham LR, Eas PF, Bloss JL, Dajani EZ, Clay GA: Antidiarrheal and central nervous system activities of SC-27166 (2-[3-(5-methyl-1,3,4-oxadiazol-2-yl)-3,3-diphenylpropyl]-2-azabicyclo[2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. J Pharmacol Exp Ther 203:527–538, 1977
Stahl KD, Van Bever W, Janssen P, Simon EJ: Receptor affinity and pharmacological potency of a series of narcotic analgesicm anti-diarrheal and neuroleptic drugs. Eur J Pharmacol 46:199–205, 1977
Simon EJ, Hiller JM: The opiate receptors. Annu Rev Pharmacol Toxicol 18:371–394, 1978
Terenius L: Comparison between narcotic “receptors” in the guinea-pig ileum and the rat brain. Acta Pharmacol Toxicol 37:211–221, 1975
Wüster M, Schulz R, Herz A: Opiates compared with antidiarrheals concerning their affinity to the morphine receptor and action on the isolated guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 293(suppl):R35, 1976
Zavecz JH, Jackson TE, Limp GL, Yellin TO: Relationship between antidiarrheal activity and binding to calmodulin. Eur J Pharmacol 78:375–377, 1982
Merritt JE, Brown BL, Tomlinson S: Loperamide and calmodulin. Lancet 1:283, 1982
Stoll R, Ruppin H, Domschke W: Calmodulin-mediated effects of loperamide on chloride transport by brush border membrane vesicles from human ileum. Gastroenterology 95:69–76, 1988
Kenakin TP, Beek D: A comparison of loperamide to four calcium channel inhibitors on isolated tissues; loperamide as a calcium channel blocker. The Pharmacologist 24:193, 1982
Chang EB, Brown DR, Wang NS, Field M: Loperamide selectively inhibits peptide-induced Cl−-secretion and calcium entry in gut. Gastroenterology 86:1044A, 1984
Fioramonti J, Fargeas M-J, Buéno L: Stimulation of gastrointestinal motility by loperamide in dogs. Dig Dis Sci 32:641–646, 1987
Read M, Read NW: Anal sphincter function in diarrhoea: Influence of loperamide. Clin Res Reviews 1(suppl 1):219–224, 1981
Rees WDW, Sharpe GR, Christofides ND, Bloom SR, Turnberg LA: The effects of an opiate agonist and antagonist on the human upper gastrointestinal tract. Eur J Clin Invest 13:221–225, 1983
Remington M, Malagelada J-R, Zinsmeister A, Fleming CR: Abnormalities in gastrointestinal motor activity in patients with short bowels: Effect of a synthetic opiate. Gastroenterology 85:629–636, 1983
Altaparmakov I, Wienbeck M: Local inhibition of myoelectrical activity of human colon by loperamide. Dig Dis Sci 29:232–238, 1984
Cann PA, Read NW, Holdsworth CD, Barends D: Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci 29:239–247, 1984
Emblem R, Stien R, Mørkrid L: The effect of loperamide on bowel habits and anal sphincter function in patients with ileoanal anastomosis. Scand J Gastroenterol 24:1019–1024, 1989
Baker GF, Segal MB: The effect of loperamide on the ion fluxes across the isolated rabbit colon. Biochem Pharmacol 30:3371–3373, 1981
Balkovetz DF, Miyamoto Y, Tiruppathi C, Mahesh VB, Leibach FH, Ganapathy V: Inhibition of brush-border membrane Na+−H+ exchanger by loperamide. J Pharmacol Exp Ther 243:150–154, 1987
Beubler E, Lembeck F: Inhibition of stimulated fluid secretion in the rat small and large intestine by opiate agonists. Naunyn-Schmiedeberg's Arch Pharmacol 306:113–118, 1979
Beubler E, Badhri P: Comparison of the antisecretory effects of loperamide and loperamide oxide in the jejunum and the colon of ratsin vivo. J Pharm Pharmacol 42:689–692, 1990
Binder HJ, Laurenson J, Dobbins JW: Mechanism of loperamide's antidiarrheal action. Gastroenterology 80:1111, 1981
Brown DR, Treder BG: Neurohormonal regulation of ion transport in the porcine distal jejunum. Actions of neurotensin and its natural homologs. J Pharm Exp Ther 249:348–357, 1989
Chang EB, Brown DR, Wang NS, Field M: Secretagogueinduced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide. J Clin Invest 78:281–287, 1986
Diener M, Knobloch SF, Rummel W: Action of loperamide on neuronally mediated and Ca2+-or cAMP-mediated secretion in rat colon. Eur J Pharmacol 152:217–225, 1988
Duenas Laita A, Fernandez De La Gandara F, Caro-Paton Gomez A, Casas Carnicero J: Modificationes del transporte de agua, glucosa y electrolitos en el intestino de rata “in vivo” tras la inyección intraluminal de loperamida y aspirina. Rev Esp Enf Ap Digest 64:165–169, 1983
Farack UM, Kautz U, Loeschke K: Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin. Naunyn-Schmiedeberg's Arch Pharmacol 317:178–179, 1981
Goerg KJ, Roux M, Wanitschke R, Meyer zum Büschenfelde KH: The direct and indirect inhibitory effect of loperamide on active chloride secretion in the colon induced by prostaglandin E2, prostacyclin and iloprost. Gastroenterology 88:1397, 1985
Gordon SJ, Kinsey MD, Magen JS, Joseph RE, Kowlessar OD: Effect of loperamide on bile acid induced secretion in the rat cecum. Gastroenterology 74:1040, 1978
Guandalini S, Fasano A, Rao MC, Ferola A, Migliavacca M, Marchesano G, Rubino A: Effects of loperamide on intestinal ion transport. J Pediatr Gastroenterol Nutr 3:593–601, 1984
Hardcastle J, Hardcastle PT, Read NW, Redfern JS: The action of loperamide in inhibiting prostaglandin-induced intestinal secretion in the rat. Br J Pharmacol 74:563–569, 1981
Hardcastle J, Hardcastle PT, Cookson J: Inhibitory actions of loperamide on absorptive processes in rat small intestine. Gut 27:686–694, 1986
Ilundain A, Naftalin RJ: Opiates increase chloride permeability of the serosal border of rabbit ileum. J Physiol 316:56–57, 1981
Karbach U, Dix J, Ewe K: Einfluss von Loperamid auf den intestinalen Flüssigkeitstransport.In vivo Untersuchung am Dünndarm der Ratte. Klin Wochenschr 64 (suppl V):60, 1986
Knoop FC, Abbey DM: Effect of chemical and pharmacological agents on the secretory activity induced byEscherichia coli heat-stable enterotoxin. Can J Microbiol 27:754–758, 1981
Loeschke K, Schmid T, Farack UM: Inhibition by loperamide of mucus secretion in the rat colonin vivo. Eur J Pharmacol 170:41–46, 1989
Sandhu BK, Tripp JH, Candy DCA, Harries JT: Loperamide inhibits cholera-toxin-induced small-intestinal secretion. Lancet 2:689–690, 1979
Sandhu BK, Tripp JH, Candy DCA, Harries JT: Loperamide: studies on its mechanism of action. Gut 22:658–662, 1981
Stoll R, Ruppin H, Domschke W: Effect of loperamide on chloride transport in brush border vesicles of human small intestine. Gastroenterology 88:1601, 1985
Verhaeren EHC, Dreessen MJ, Lemli JA: Influence of 1,8-dihydroxyanthraquinone and loperamide on the paracellular permeability across colonic mucosa. J Pharm Pharmacol 33:526–528, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Awouters, F., Megens, A., Verlinden, M. et al. Loperamide. Digest Dis Sci 38, 977–995 (1993). https://doi.org/10.1007/BF01295711
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01295711